- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01070199
Effects of Food Form and Fitness on Appetite and Digestion.
22. juli 2011 opdateret af: Purdue University
Energy-yielding fluids induce weaker appetitive and compensatory dietary responses than energy-matched semi-solids or solids.
This is problematic because the high and increasing contribution of energy from beverages in the diet may enhance positive energy balance and weight gain.
The prevailing view of the overweight/obesity problem is that it stems from a small, sustained positive energy balance.
It follows then that only small changes, perhaps manipulations in the rheological characteristics of the diet, will be required to correct the problem.
Certain populations that are more prone to weight gain may benefit from such manipulations.
Obese individuals have a higher beverage intake and experience greater weight loss with reductions in beverage intake.
Further, there is evidence that obese individuals consume more energy after a liquid pre-load than their lean counterparts, yet there is no difference in energy intake after a solid load.
In contrast, habitual exercisers have been shown to have an increased accuracy of short-term regulation of food intake at meals following liquid preloads.
A better understanding of the mechanisms by which beverages and energy-matched solid food forms elicit differential appetitive and dietary responses in these populations needed.
This research will attempt to identify the influence of physical fitness and body fat on the ability to compensate for the energy content of solid and liquid preloads by reduction in energy intake at a subsequent ad libitum meal (i.e., acute compensation) and over the course of the day (i.e., short-term compensation).
Furthermore, this study will examine the cognitive contribution to differential responses to energy-matched beverage and solid food forms and the effects of mastication on appetite, GI transit, glycemic response, and selected endocrine responses.
Studieoversigt
Status
Afsluttet
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
81
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Indiana
-
West Lafayette, Indiana, Forenede Stater, 47907
- Purdue University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 50 år (Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- 18-50 years of age BMI of 18-23 kg/m2 (lean) or 30-35 kg/m2 (obese) Sedentary physical activity level (<70th¬ percentile of estimated VO2max for age and sex) or physically Active/Exercisers (>70th¬ percentile of estimated VO2max for age and sex) Good health and not taking any medications known to influence appetite Non-smokers Not pregnant or lactating Weight stable (≤ 3 kg within last 3 months) Dietary restraint score <11 on the Three Factor Eating Questionnaire (included in the on-line screening questionnaire) Glucose Tolerant or Non-Diabetic (fasting blood glucose of <100 mg/dL) Self-reported consumer of breakfast and lunch
Exclusion Criteria:
- History or presence of significant metabolic diseases that may impact study results (i.e., endocrine, hepatic, renal disease) Individuals planning on starting a new diet or exercise regimen during the course of the study Use of obesity pharmacotherapeutic agents or over-the counter anti-obesity agents within the last 3 months Underlying conditions such as any cardiovascular, pulmonary, or neurological dysfunction that may be aggravated with exercise
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: liquid to liquid,
|
• One test session will involve presentation of a glass of clear cherry-flavored unthickened beverage (Kool-Aid, Kraft Foods Inc., White Plains, NY).
This session will be referred to as the "Liquid to Liquid" session as the participants will be consuming a liquid and be told that the consistency in their stomach will be a liquid.
Andre navne:
|
|
Eksperimentel: liquid to solid,
|
This session involves a solution of calcium chloride and a solution of sodium alginate.
The participant will be instructed to pour the cherry-flavored beverage/alginate solution into the calcium chloride.
The result is a solid mass.
They are allowed to examine the solution to confirm the solid texture and consistency.Participants will be told that this same reaction will occur in their stomach when the session's beverage is consumed due to the effect of gastric acid on the solution.
But, the participant will be consuming the same cherry-flavored beverage as in the 1st session.
Thus, they will believe that their GI tract will be challenged with a solid mass, but in reality, the challenge is the same (i.e., liquid).Therefore, the only difference between the test sessions is expectation.
Andre navne:
|
|
Eksperimentel: solid to liquid
|
• This session will involve the same dense gelatin cubes previously described, but participants will be told that the solid cubes will turn to liquid when they come into contact with the acid in their stomach.
This trial will be known as "Solid to Liquid".
A demonstration of the "Solid to Solid" and "Solid to Liquid" phases will be shown to the participant before they consume the load.
Both phases exhibited by placing two cubes into separate containers filled with similar looking clear liquids.
The "Solid to Solid" phase container will contain cold water so the cube stays in solid form.
The "Solid to Liquid" phase container will contain hot water that will quickly dissolve the cube into a liquid form.
Andre navne:
|
|
Eksperimentel: solid to solid
|
Participants will be presented with dense gelatin cubes.
These 1" x 1" x 1" cubes will have a solid appearance and require mastication, but is isocaloric to the beverage.
However, after mastication and gastric processing, the solid rapidly breaks down into a clear fluid.However, participants will be informed that the cubes will remain the same solid consistency in their stomach.
The masticatory process and stimulus form will be standardized through the use of a metronome.
Participants will be required to chew the solid cube at a fixed rate prior to swallowing.
Thus, adding to the cognitive impression that they are eating a solid when essentially the GI challenge will be similar to the beverage.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change of energy intake.
Tidsramme: 24 hours
|
Effects of actual and perceived food form on short term energy intake in lean and obese, fit and unfit adults.
|
24 hours
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change of appetite.
Tidsramme: 4 hours
|
Effects of actual and perceived food form on hunger, fullness, desire to eat, and thirst.
|
4 hours
|
|
Gastric emptying
Tidsramme: 4 hours
|
Effects of actual and perceived food form on gastric emptying time.
|
4 hours
|
|
Gastro-intestinal transit
Tidsramme: 4 hours
|
Effects of actual and perceived food form on gastro-intestinal transit time.
|
4 hours
|
|
Endocrin responses
Tidsramme: 4 hours
|
Effects of actual and perceived food form on GLP-1, CCK, Insulin, Ghrelin concentration.
|
4 hours
|
|
Glucose response
Tidsramme: 4 hours
|
Effects of actual and perceived food form on serum glucose concentration.
|
4 hours
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. januar 2009
Primær færdiggørelse (Faktiske)
1. december 2009
Studieafslutning (Faktiske)
1. december 2010
Datoer for studieregistrering
Først indsendt
16. februar 2010
Først indsendt, der opfyldte QC-kriterier
16. februar 2010
Først opslået (Skøn)
17. februar 2010
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
25. juli 2011
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
22. juli 2011
Sidst verificeret
1. juli 2011
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- R01DK079913 (U.S. NIH-bevilling/kontrakt)
- 0805006922 (Anden identifikator: Purdue University)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med liquid to liquid
-
American University of Beirut Medical CenterNational Institute on Drug Abuse (NIDA); National Institutes of Health...AfsluttetVurder indflydelsen af nikotinflux og nikotinform på subjektive effekter relateret til afhængighedNikotin afhængighed | Nikotindampning | Nikotin afhængighedLibanon
-
Vedanta University ClinicRekruttering
-
TargetCancer FoundationFoundation MedicineRekrutteringCholangiocarcinom | Kræft på ukendt primært sted | Sjældne kræftformerForenede Stater
-
West China HospitalAfsluttetKarcinom, ikke-småcellet lunge | Kemoterapi, AdjuvansKina
-
Merakris TherapeuticsLedigTryksår | Kirurgisk sår dehiscens | Diabetisk ulcus | Iskæmisk sår | Kutan sår | Forbrændinger - flere | Blandet sårForenede Stater
-
China Academy of Chinese Medical SciencesXiyuan Hospital of China Academy of Chinese Medical SciencesUkendt
-
Guangzhou Yipinhong Pharmaceutical CO.,LTDAfsluttetAkut øvre luftvejsinfektionKina
-
Quan JiangIkke rekrutterer endnu
-
Addario Lung Cancer Medical InstituteAktiv, ikke rekrutterende
-
PlaqueTec LtdRoyal Papworth HospitalRekrutteringKoronararteriesygdomDet Forenede Kongerige